Molecular biology and cerebrovascular diseases

Neurological Surgery

Volumn 27, Issue 2, 1999, Pages 111-118

  Kirino, Takaaki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Apoptosis; Gene therapy; Genetics; Molecular biology; Vascular biology

Indexed keywords

ARGININE; CALCIUM; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOGLIN; GLUTAMIC ACID; LOW DENSITY LIPOPROTEIN; N METHYL DEXTRO ASPARTIC ACID; OXYGEN RADICAL; TACROLIMUS; THYMIDINE KINASE; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BINDING PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ATHEROSCLEROSIS; AUTOSOMAL DOMINANT DISORDER; CEREBROVASCULAR DISEASE; EHLERS DANLOS SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MELAS SYNDROME; MOLECULAR BIOLOGY; MOLECULAR CLONING; NUCLEAR MAGNETIC RESONANCE IMAGING; PENETRANCE; RENDU OSLER WEBER DISEASE; REVIEW;

ANIMALS; APOPTOSIS; BRAIN; CEREBROVASCULAR DISORDERS; GENE THERAPY; HUMANS; MOLECULAR BIOLOGY;

EID: 0032934460     PISSN: 03012603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Anderson WF: Human gene therapy. Nature 392 (Suppl) : 25-30, 1998
2. Anonymous: Tissue plasminogen activator for acute ischemic stroke. The National Insitute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 333: 1581-1587, 1995
3. Asano T, Matsui T: Various pathogenetic factors revolving around the central role of protein kinase C activation in the occurrence of cerebral vasospasm. Crit Rev Neurosurg 8: 176-187, 1988
4. Barinaga M: Finding new drugs to treat stroke. Science 272: 664-666, 1996
5. ++-permeable AMPA receptors in delayed neurodegeneration. Cold Spring Harb Symp Quant Biol 1996, 61: 373-384, 1996
6. Bonn D: First cell transplant aimed to reverse stroke damage. Lancet 352: 119, 1998
7. Bonventre JV, Huang Z, Taheri MR, O'Leary E, Li E, Moskowitz MA, Sapirstein A: Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 390: 622-625, 1997
8. Breslow JL: Mouse models of atherosclerosis. Science 272: 685-688, 1996
9. Chang MW, Barr E, Seltzer J, Jiang YQ, Nabel GJ, Nabel EG, Parmacek MS, Leiden JM: Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 267: 518-522, 1995
10. Chen J, Nagayama T, Jin K, Stetler RA, Zhu RL, Graham SH, Simon RP: Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J Neurosci 18: 4914-4928, 1998
11. Choi DW: Ischemia-induced neuronal apoptosis. Current Opinion in Neurobiology 6: 667-672, 1996
12. Collen D: Staphylokinase: a potent, uniquely fibrin-selective thrombolytic agent. Nat Med 4: 279-284, 1998
13. Connolly ES Jr, Winfree CJ, Prestigiacomo CJ, Kim SC, Choudhri TF, Hoh BL, Naka Y, Solomon RA, Pinsky DJ: Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke. Circ Res 81: 304-310, 1997
14. Cornejo CJ, Winn RK, Harlan JM: Anti-adhesion therapy. Adv Pharmacol 39: 99-142, 1997
15. Crumrine RC, Thomas AL, Morgan PF: Attenuation of p53 expression protects against focal ischemic damage in transgenic mice. J Cereb Blood Flow Metab 14: 887-891, 1994
16. DeGraba TJ, Penix L: Genetics of ischemic stroke. Curr Opin Neurol 8: 24-29, 1995
17. Eliasson MJ, Sampei K, Mandir AS, Hurn PD, Traystman RJ, Bao J, Pieper A, Wang ZQ, Dawson TM, Snyder SH, Dawson VL: Poly (ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 3: 1089-1095, 1997
18. Friedlander RM, Gagliardini V, Hara H, Fink KB, Li W, MacDonald G, Fishman MC, Greenberg AH, Moskowitz MA, Yuan J: Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J Exp Med 185: 933-940, 1997
19. Gage FH: Cell therapy. Nature 392 (6679 Suppl): 18-24, 1998
20. Gibbons GH, Dzau VJ: Molecular therapies for vascular diseases. Science 272: 689-693, 1996
21. 2+ influx in hippocampal CA1 neurons of gerbil. J Neurosci 17: 6179-6188, 1997
22. Goto Y, Nonaka I, Horai S: A mutation in the tRNA (Leu) (UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348: 651-653, 1990
23. Graeber MB, Muller U: Recent developments in the molecular genetics of mitochondrial disorders. J Neurol Sci 153: 251-263, 1998
24. Gunel M, Awad IA, Anson J, Lifton RP: Mapping a gene causing cerebral cavernous malformation to 7q11.2-q21. Proc Natl Acad Sci USA 92: 6620-6624, 1995
25. Hara H, Fink K, Endres M, Friedlander RM, Gagliardini V, Yuan J, Moskowitz MA: Attenuation of transient focal cerebral ischemic injury in transgenic mice expressing a mutant ICE inhibitory protein. J Cereb Blood Flow Metab 17: 370-375, 1997
26. Hara H, Friedlander RM, Gagliardini V, Ayata C, Fink K, Huang Z, Shimizu Sasamata M, Yuan J, Moskowitz MA: Inhibition of interleukin 1 beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 94: 2007-2012, 1997
27. Hilbert P, Lindpaintner K, Beckmann JS, Serikawa T, Soubrier F, Dubay C, Cartwright P, De Gouyon B, Julier C, Takahasi S, et al: Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats. Nature 353: 521-529, 1991
28. Ho DY, Sapolsky RM: Gene therapy for the nervous system. Sci Am 276: 116-120, 1997
29. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA: Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265: 1883-1885, 1994
30. Iadecola C: Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 20: 132-139, 1997
31. Iadecola C, Zhang F, Casey R, Nagayama M, Ross ME: Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 17: 9157-9164, 1997
32. Jeffs B, Clark JS, Anderson NH, Gratton J, Brosnan MJ, Gauguier D, Reid JL, Macrae IM, Dominiczak AF: Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus. Nat Genet 16: 364-367, 1997
33. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cecillion M, Marechal E, Maciazek J, Vayssiere C, Cruaud C, Cabanis EA, Ruchoux MM, Weissenbach J, Bach JF, Bousser MG, Tournier Lasserve E: Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383: 707-710, 1996
34. Karpati G, Lochmuller H, Nalbantoglu J, Durham H: The principles of gene therapy for the nervous system. Trends Neurosci 19: 49-54, 1996
35. Keller JN, Kindy MS, Holtsberg FW, St Clair DK, Yen HC, Germeyer A, Steiner SM, Bruce Keller AJ, Hutchins JB, Mattson MP: Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci 18: 687-697, 1998
36. Leblanc R: Familial cerebral aneurysms. Can J Neurol Sci 24: 191-199, 1997
37. Levy E, Carman MD, Fernandez Madrid IJ, Power MD, Lieberburg I, van Duinen SG, Bots GT, Luyendijk W, Frangione B: Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248: 1124-1126, 1990
38. Liu PK, Hsu CY, Dizdaroglu M, Floyd RA, Kow YW, Karakaya A, Rabow LE, Cui JK: Damage, repair, and mutagenesis in nuclear genes after mouse forebrain ischemia-reperfusion. J Neurosci 16: 6795-6806, 1996
39. MacManus JP, Linnik MD: Gene expression induced by cerebral ischemia: an apoptotic perspective. J Cereb Blood Flow Metab 17: 815-832, 1997
40. Martinou J-C, Dubois-Dauphin M, Staple JK, Rodriguez I, Frankowski H, Missotten M, Albertini P, Talabot D, Catsicas S, Pietra C, Huarte J: Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13: 1017-1030, 1994
41. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J, et al: Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8: 345-351, 1994
42. Morikawa E, Zhang S-M, Seko Y, Toyoda T, Kirino T: Treatment of focal cerebral ischemia with synthetic oligopeptide corresponding to lectin domain of selectin. Stroke 27: 951-956, 1996
43. Morishita R, Gibbons GH, Horiuchi M, Ellison KE, Nakama M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ: A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc Natl Acad Sci USA 92: 5855-5859, 1995
44. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J, Ogihara T: In vivo transfection of cis element "decoy" anainst nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med 3: 894-899, 1997
45. Muhonen MG, Ooboshi H, Welsh MJ, Davidson BL, Heistad DD: Gene transfer to cerebral blood vessels after subarachnoid hemorrhage. Stroke 28: 822-828, 1997
46. Murakami K, Kondo T, Kawase M, Li Y, Sato S, Chen SF, Chan PH: Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci 18: 205-213, 1998
47. Namura S, Zhu J, Fink K, Endres M, Srinivasan A, Tomaselli KJ, Yuan J, Moskowitz MA: Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci 18: 3659-3668, 1998
48. Ohno T, Gordon D, San H, Pompili VJ, Imperiale MJ, Nabel GJ, Nabel EG: Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 265: 781-784, 1994
49. Pettmann B, Henderson CE: Neuronal cell death. Neuron 20: 633-647, 1998
50. Plumier JC, Krueger AM, Currie RW, Kontoyiannis D, Kollias G, Pagoulatos GN: Transgenic mice expressing the human inducible Hsp70 have hippocampal neurons resistant to ischemic injury. Cell Stress Chaperones 2: 162-167, 1997
51. Rastenyte D, Tuomilehto J, Sarti C: Genetics of stroke: a review. J Neurol Sci 153: 132-145, 1998
52. Ronkainen A, Hernesniemi J, Puranen M, Niemitukia L, Vanninen R, Ryynanen M, Kuivaniemi H, Tromp G: Familial intracranial aneurysms. Lancet 319: 380-384, 1997
53. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809, 1993
54. Schielke GP, Yang GY, Shivers BD, Betz AL: Reduced ischemic brain injury in interleukin-1 beta converting enzyme-deficient mice. J Cereb Blood Flow Metab 18: 180-185, 1998
55. Schievink WI, Michels VV, Piepgras DG: Neurovascular manifestations of heritable connective tissue disorders: a review. Stroke 25: 889-903, 1994
56. Schievink WI, Schaid DJ, Rogers HM, Piepgras DG, Michels VV: On the inheritance of intracranial aneurysms. Stroke 25: 2028-2037, 1994
57. Schievink WI: Genetics of intracranial aneurysms. Neurosurgery 40: 651-662, 1997
58. Sharma P: Genes for ischaemic stroke: strategies for their detection. J Hypertens 14: 277-285, 1996
59. Soriano SG, Lipton SA, Wang YF, Xiao M, Springer TA, Gutierrez Ramos JC, Mickey PR: Intercellular adhesion molecule-1-deficient mice are less susceptible to cerebral ischemia-reperfusion injury. Ann Neurol 39: 618-624, 1996
60. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995
61. Tsubokawa H, Oguro K, Robinson HP, Masuzawa T, Kawai N: Single glutamate channels in CA1 pyramidal neurones after transient ischaemia. Neuroreport 6: 527-523, 1995
62. Van Broeckhoven C, Haan J, Bakker E, Hardy JA, Van Hul W, Wehnert A, Vegter Van der Vlis M, Roos RA: Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science 248: 1120-1122, 1990
63. Wahlestedt C, Golanov E, Yamamoto S, Yee F, Ericson H, Yoo H, Inturris CE, Reis DJ: Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions. Nature 363: 260-263, 1993
64. Wang YF, Tsirka SE, Strickland S, Stieg PE, Soriano SG, Lipton SA: Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med 4: 228-231, 1998
65. Xu DG, Crocker SJ, Doucet JP, Stjean M, Tamai K, Hakim AM, Ikeda JE, Lipton P, Thompson CS, Korneluk RG, MackKenzie A, Robertson GS: Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nature Med 3: 997-1004, 1997
66. Zamzami N, Hirsch T, Dallaporta B, Petit PX, Kroemer G: Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis. J Bioenerg Biomembr 29: 185-193, 1997
67. Zhang F, Eckman C, Younkin S, Hsiao KK, IadecoIa C: Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein. J Neurosci 17: 7655-7661, 1997